Robert F. Kennedy Jr., an anti-vaccine activist, has been chosen as President-elect Donald Trump&rsq..
..Read More
The wellness economy is booming and hit a record high of $6.3 trillion globally in 2023. It is expec..
..Read More
The government may soon urge Americans to cut back on their beef patties. A new Dietary Guidelines A..
..Read More
A recent Office of Inspector General (OIG) report reveals that Medicare paid private insurers billio..
..Read More
The Biden administration proposed a new rule yesterday that mandates insurance to cover over-the-cou..
..Read More
A 12-year-old boy from Washington, Kendric Cromer, became the first commercial patient to complete a..
..Read More
Over 200 pregnant women in the US faced criminal charges for pregnancy-related conduct in the year a..
..Read More
For decades, obesity has been on the rise, but with the new weight loss medications, the US adult ob..
..Read More
The Food and Drug Administration (FDA) has approved Cobenfy, the first new treatment for schizophren....
..Read More
The Federal Trade Commission announced a lawsuit against three major pharmacy benefit managers (PBMs..
..Read More
Stanford researchers have discovered that aging occurs in distinct “waves” around ages 4..
..Read More
A Boar’s Head deli meat plant in Virginia is linked to a nationwide listeria outbreak, leading..
..Read More
Surgeon General Dr. Vivek Murthy issued a warning on Wednesday that parenting is increasingly stress..
..Read More
The WHO declared mpox a public health emergency of international concern (PHEIC) after a global outb..
..Read More
Federal health insurance plan Medicare successfully negotiated lower prices for the 10 most commonly..
..Read More
The Food and Drug Administration (FDA) rejected Lykos Therapeutics’ request to approve an MDMA..
..Read More
The Food and Drug Administration (FDA) approved the use of Shield, a blood test by Guardant Health, ..
..Read More
The Food and Drug Administration (FDA) approved Eli Lilly’s Alzheimer’s drug, Kisunla, c..
..Read More
The Federal Trade Commission (FTC) is investigating Teva Pharmaceuticals for keeping patents on asth..
..Read More
A new study published in Environment International found that chemicals, known as PFAS (or “fo..
..Read More
A new study published in the Lancet Regional Health—Europe journal reveals that not all plant-..
..Read More
An increasing number of instances of undertrained call center employees assisting elderly patients w..
..Read More
Top executives of an ADHD telehealth company, Done Global Inc., were arrested on charges of healthca....
..Read More
Justices of the Supreme Court of the United States unanimously rejected a lawsuit yesterday that sou..
..Read More
The only two medical marijuana dispensaries in Martha’s Vineyard, catering to over 230 registe..
..Read More
Researchers have discovered a worrying connection between xylitol, a popular low-calorie sweetener a..
..Read More
An advisory committee on Tuesday overwhelmingly voted to recommend the Food and Drug Administration ..
..Read More
The Food and Drug Administration (FDA) expressed concerns about using MDMA (commonly known as Ecstas..
..Read More
Louisiana recently became the first state to criminalize abortion drugs mifepristone and misoprostol..
..Read More
The trend of drinking raw milk is gaining popularity on social media, with users claiming it has hea..
..Read More
No fillers. No hidden agenda. News as it should be.
Daily Shorts is a fresh media company that focuses on you. Our goal is to empower you with unbiased and easy-to-digest information to help you grow and understand the world better.
We believe reading news is a lost art. Clickbait journalism and loud media narratives are constantly telling you what to think. At Daily Shorts, you will only find the news most relevant to you.
We are fuelled by curiosity and dedicated to writing stories that would excite and move every reader. Fulfilling these promises requires Daily Shorts to reach every person’s inbox. And this is why we decided not to charge you for subscription.
We are free and will always be because we believe that quality journalism is not a luxury or exclusive to a few, but everyone’s right.
We make news reading fun.
This website uses cookies or similar technologies, to enhance your browsing experience and provide personalized recommendations. By continuing to use our website, you agree to our Privacy Policy